Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Conte

Showing results (241-250 of 287) with videos related to

Pageof 29
Sort By:
Journal of Vascular Surgery|November 25, 2018
Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse modelMichael Spinosa, Gang Su, Morgan D Salmon, et al.
Journal of Vascular Surgery|December 5, 2024
Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trialJeffrey J Siracuse, Alik Farber, Matthew T Menard, et al.
Journal of Vascular Surgery|February 2, 2015
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication, Michael S Conte, Frank B Pomposelli, et al.
Journal of Vascular Surgery|November 8, 2025
Influence of specialty on endovascular practice patterns and outcomes in the BEST-CLI TrialRichard J Powell, Matthew T Menard, Kenneth Rosenfield, et al.
Journal of Vascular Surgery|October 1, 2019
Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemiaJoep G J Wijnand, Ian D van Koeverden, Martin Teraa, et al.
Journal of Vascular Surgery|July 28, 2024
The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI TrialMatthew T Menard, Alik Farber, Gheorghe Doros, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 23, 2026
Major Adverse Limb Events and Death After Successful Endovascular Revascularization: BEST-CLI TrialScott Kinlay, Alik Farber, Matthew T Menard, et al.
Diabetes Care|May 30, 2025
High Transepidermal Water Loss at the Site of Wound Closure Is Associated With Increased Recurrence of Diabetic Foot Ulcers: The NIDDK Diabetic Foot Consortium TEWL StudyChandan K Sen, Gayle M Gordillo, Sashwati Roy, et al.
The British Journal of Surgery|June 2, 2026
Frailty and the Efficacy and Safety of Surgical vs Endovascular Revascularisation: A Post Hoc Analysis of the BEST-CLI TrialDarae Ko, Peter T Evans, Chan Mi Park, et al.
Journal of Vascular Surgery|November 26, 2022
Relationship between WIfI stage and quality of life at revascularization in the BEST-CLI trialJeffrey J Siracuse, Vincent L Rowe, Matthew T Menard, et al.
Pageof 29

Showing results (241-250 of 287) with videos related to

Sort By:
Pageof 29
Journal of Vascular Surgery|November 25, 2018
Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse modelMichael Spinosa, Gang Su, Morgan D Salmon, et al.
Journal of Vascular Surgery|December 5, 2024
Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trialJeffrey J Siracuse, Alik Farber, Matthew T Menard, et al.
Journal of Vascular Surgery|February 2, 2015
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication, Michael S Conte, Frank B Pomposelli, et al.
Journal of Vascular Surgery|November 8, 2025
Influence of specialty on endovascular practice patterns and outcomes in the BEST-CLI TrialRichard J Powell, Matthew T Menard, Kenneth Rosenfield, et al.
Journal of Vascular Surgery|October 1, 2019
Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemiaJoep G J Wijnand, Ian D van Koeverden, Martin Teraa, et al.
Journal of Vascular Surgery|July 28, 2024
The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI TrialMatthew T Menard, Alik Farber, Gheorghe Doros, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 23, 2026
Major Adverse Limb Events and Death After Successful Endovascular Revascularization: BEST-CLI TrialScott Kinlay, Alik Farber, Matthew T Menard, et al.
Diabetes Care|May 30, 2025
High Transepidermal Water Loss at the Site of Wound Closure Is Associated With Increased Recurrence of Diabetic Foot Ulcers: The NIDDK Diabetic Foot Consortium TEWL StudyChandan K Sen, Gayle M Gordillo, Sashwati Roy, et al.
The British Journal of Surgery|June 2, 2026
Frailty and the Efficacy and Safety of Surgical vs Endovascular Revascularisation: A Post Hoc Analysis of the BEST-CLI TrialDarae Ko, Peter T Evans, Chan Mi Park, et al.
Journal of Vascular Surgery|November 26, 2022
Relationship between WIfI stage and quality of life at revascularization in the BEST-CLI trialJeffrey J Siracuse, Vincent L Rowe, Matthew T Menard, et al.
Pageof 29